Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension
- 1 April 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 86 (4) , 110-114
- https://doi.org/10.1016/0002-9343(89)90203-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics and pharmacodynamics of isradipine (PN 200-110) in young and elderly patientsThe American Journal of Medicine, 1988
- Approach to the treatment of hypertension in older patients: Preliminary results with isradipineThe American Journal of Medicine, 1988
- Clinical pharmacokinetics of isradipineThe American Journal of Medicine, 1988
- Pharmacokinetics of PN 200-110 (isradipine), a new calcium antagonist, after oral administration in manEuropean Journal of Clinical Pharmacology, 1987
- Antihypertensive activity of isradipine in humans: A new dihydropyridine calcium channel antagonistClinical Pharmacology & Therapeutics, 1986
- EFFICACY OF ANTIHYPERTENSIVE DRUG TREATMENT ACCORDING TO AGE, SEX, BLOOD PRESSURE, AND PREVIOUS CARDIOVASCULAR DISEASE IN PATIENTS OVER THE AGE OF 60The Lancet, 1986
- Hypertension in the Elderly: TreatmentCardiology Clinics, 1986
- Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention TrialThe American Journal of Cardiology, 1985
- Effects of Treatment on Morbidity in HypertensionCirculation, 1972
- Systolic Hypertension in the ElderlyCirculation, 1970